About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Minneapolis | 7,812 Studies Near You

Clinical TrialsMinneapolis

Clinical Trials in Minneapolis

Discover 7,812 clinical trials near Minneapolis, Minnesota. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 4101-4120 of 7,812 trials

CompletedA Study of PTC923 (CNSA-001) in Primary Tetrahydrobiopterin (BH4) Deficient Participants With HyperphenylalaninemiaThis study has been designed to demonstrate the safety, pharmacokinetics (PK) and preliminary efficacy of PTC923 (CNSA-001) in reducing blood phenylalanine concentrations in…NCT03519711·Minneapolis, Minnesota and 3 others CompletedStudy to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic DermatitisB7451015 is a Phase 3 study to evaluate Abrocitinib with or without Topical Medications in patients aged 12 years and older who have moderate to severe atopic dermatitis and have…NCT03422822·Birmingham, Alabama and 538 others

Find Trials by Condition in Minneapolis

Breast Cancerin Minneapolis Lung Cancerin Minneapolis Prostate Cancerin Minneapolis Colorectal Cancerin Minneapolis Melanomain Minneapolis Leukemiain Minneapolis Lymphomain Minneapolis Pancreatic Cancerin Minneapolis Ovarian Cancerin Minneapolis Brain Cancerin Minneapolis

Data from ClinicalTrials.govTerms

CompletedStudy of Remdesivir in Participants Below 18 Years Old With COVID-19The goals of this clinical study are to learn more about the study drug, remdesivir, and how safe it is in participants less than 18 years old with coronavirus disease 2019…NCT04431453·Birmingham, Alabama and 31 others

CompletedStudy to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of INCB000928 in Participants With Impaired Renal Function and HemodialysisThis is a multicenter, open-label parallel-group to evaluate single oral doses of INCB000928 in participants with varying level of renal function or impairment.NCT05099445·Rialto, California and 4 others

CompletedSwitch Study to Evaluate F/TAF in HIV-1 Positive Participants Who Are Virologically Suppressed on Regimens Containing FTC/TDFThis study will evaluate the efficacy of switching from emtricitabine/tenofovir disoproxil fumarate (FTC/TDF) fixed dose combination (FDC) to emtricitabine/tenofovir alafenamide…NCT02121795·Birmingham, Alabama and 77 others

CompletedROMAN: Phase 3 Trial Investigating the Effects of GC4419 on Radiation Induced Oral Mucositis in Head/Neck Cancer PatientsThe purpose of the phase 3, clinical study is to determine if GC4419 (avasopasem manganese) administered prior to intensity-modulated radiation therapy (IMRT) reduces the severity…NCT03689712·Gilbert, Arizona and 96 others

TerminatedTrial of LAVA-1207 in Patients With Therapy Refractory Metastatic Castration Resistant Prostate Cancer (mCRPC) Resistant Prostate CancerThis is a phase 1, first-in-human study to evaluate Safety, Tolerability, PK, PD, Immunogenicity, and Antitumor Activity of LAVA-1207 alone or with low dose interleukin-2 or…NCT05369000·San Francisco, California and 11 others

TerminatedAllogeneic Heart Stem Cells to Achieve Myocardial RegenerationThe purpose of this study is to determine whether Allogeneic Cardiosphere-Derived Cells (CAP-1002) is safe and effective in decreasing infarct size in patients with a myocardial…NCT01458405·Birmingham, Alabama and 31 others

CompletedAn Open-Label Study of JZP-458 (RC-P) in Patients With Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL)This is an open-label, multicenter, dose confirmation, and PK study of JZP-458 in patients (of any age) with ALL/LBL who are hypersensitive to E. coli-derived asparaginases…NCT04145531·Birmingham, Alabama and 73 others

CompletedCircuit-Based Deep Brain Stimulation for Parkinson's Disease; Udall Project 1 Aim 2 and 3This study will test the hypothesis that deep brain stimulation (DBS) targeting specific changes in oscillatory activity at the site of stimulation will prove superior to…NCT03079037·Minneapolis, Minnesota

CompletedAccelerated Development of Additive Pharmacotherapy Treatment (ADAPT-2) for Methamphetamine Use DisorderThis is a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy of extended-release naltrexone plus bupropion as a combination pharmacotherapy for…NCT03078075·Los Angeles, California and 7 others

Active not recruitingRituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic LeukemiaThis randomized phase III trial studies rituximab with bendamustine hydrochloride or ibrutinib to see how well they work compared to ibrutinib alone in treating older patients…NCT01886872·Birmingham, Alabama and 936 others

CompletedStudy of an Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and ToddlersThe primary objectives of the study were: * To assess the safety profile of each dose of the study product after each and any administration in all infants and toddlers…NCT04491877·Gardena, California and 28 others

CompletedEvaluation of VISITAG SURPOINT™ Module With External Processing Unit (EPU)Prospective, non-randomized, post market clinical evaluation of the VISITAG SURPOINT™ Module with External Processing Unit (EPU) when used with STSF catheter and ST catheter…NCT03624881·Birmingham, Alabama and 40 others

CompletedPrediction by Ultrasound of the Risk of Hepatic Cirrhosis in Cystic FibrosisThe specific aims for this study are: 1.NCT01144507·Aurora, Colorado and 10 others

TerminatedPreemptive Therapy for SARS-Coronavirus-2 (COVID-19 PEP Canada)Study Objective: To test if early preemptive hydroxychloroquine therapy can prevent disease progression in persons with known symptomatic COVID-19 disease, decreasing…NCT04421664·Minneapolis, Minnesota and 7 others

CompletedPediatric Hemiplegia: Synergistic Treatment Using rTMS and CITThe strategy in rehabilitating pediatric hemiplegia is to overcome "developmental disuse".NCT01104064·Minneapolis, Minnesota

TerminatedREduction of Contrast Via DyeVert Used in CTO ProceduresThe is an observational, prospective study to evaluate the effect of the DyeVert System on contrast volume administration in patients undergoing clinically-indicated chronic total…NCT03118544·Minneapolis, Minnesota and 2 others

CompletedMaximizing Outcomes in Treating Acute MigraineAXS-07 is an oral, investigational medicine consisting of MoSEIC meloxicam and rizatriptan, which is being developed for the acute treatment of migraine with or without aura in…NCT03896009·Birmingham, Alabama and 84 others

Active not recruitingAssessment of the GORE® EXCLUDER® Conformable AAA Endoprosthesis in the Treatment of Abdominal Aortic AneurysmsThe purpose of the study is to assess the safety and effectiveness of the GORE® EXCLUDER® Conformable AAA Endoprosthesis to treat an infrarenal aneurysm located in the abdominal…NCT02489539·Birmingham, Alabama and 50 others

PreviousPage 206 of 391Next

Diabetes

in Minneapolis

Heart Diseasein Minneapolis